TCI Wealth Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-106
Closed -$24.8K 1172
2023
Q1
$24.8K Buy
106
+19
+22% +$4.8K ﹤0.01% 628
2022
Q4
$21.9K Sell
87
-35
-29% -$7.46K ﹤0.01% 657
2022
Q3
$22K Hold
122
﹤0.01% 615
2022
Q2
$22K Buy
122
+41
+51% +$8.18K ﹤0.01% 610
2022
Q1
$21K Sell
81
-17
-17% -$3.88K ﹤0.01% 675
2021
Q4
$23K Hold
98
﹤0.01% 648
2021
Q3
$23K Buy
98
+83
+553% +$17.3K ﹤0.01% 628
2021
Q2
$3K Sell
15
-28
-65% -$5.55K ﹤0.01% 1768
2021
Q1
$9K Buy
+43
New +$9.14K ﹤0.01% 912
2018
Q4
Sell
-8
Closed 1532
2018
Q3
$0 Buy
+8
New +$376 ﹤0.01% 1511

Other funds holding INSP

TCI Wealth Advisors's INSP Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 106 shares — an estimated $24.8K sold.

TCI Wealth Advisors first reported a position in INSP in Q3 2018 and held it in 10 quarters. The position peaked at $24.8K in Q1 2023. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 106 Inspire Medical Systems shares in Q2 2023, an estimated $24.8K.
  • TCI Wealth Advisors first reported a position in Inspire Medical Systems in Q3 2018 and held it in 10 quarters.
  • TCI Wealth Advisors's Inspire Medical Systems position peaked at $24.8K in Q1 2023.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.